Who invested in Interleukin Genetics?
Interleukin Genetics's investors include Bay City Capital, New Enterprise Associates, Horizon Technology Finance and Delta Dental.
United States · Funded startup
4 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Interleukin Genetics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$25Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $5.0M sold, first sale Dec 2014
From a historical funding recordSEC filing: $5.0M sold, first sale Dec 2014
Reported by bizjournals.comSEC filing: $12M sold, first sale May 2013
Reported by masshightech.comSEC filing: $3.0M sold, first sale Jun 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Interleukin Genetics's investors include Bay City Capital, New Enterprise Associates, Horizon Technology Finance and Delta Dental.
Interleukin Genetics has raised $25M across 4 rounds since 2012.
Interleukin Genetics's most recent round was a Debt of $5.0M in Dec 2014.
Interleukin Genetics's largest round on record is $12M (Growth), in May 2013.
Interleukin Genetics's first round on record, in Jul 2012, was backed by Delta Dental.
Interleukin Genetics's latest named round is a Debt, in Dec 2014.
Interleukin Genetics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.